iRadimed Corporation provided earnings guidance for the first quarter and full year of 2022. For the quarter, the company expects to report revenue of $12.1 million to $12.3 million and GAAP diluted earnings per share of $0.16 to $0.18.

For the full year 2022, the company expects to report revenue of $51.4 million to $52.2 million and GAAP diluted earnings per share of $0.82 to $0.90.